Flunarizine improves the survival of grafted dopaminergic neurons
暂无分享,去创建一个
[1] J. Tillement,et al. Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition. , 1998, European journal of pharmacology.
[2] S. Finger,et al. Nimodipine enhances growth and vascularization of neural grafts , 1989, Experimental Neurology.
[3] M. Bähr,et al. Flunarizine enhances rat retinal ganglion cell survival after axotomy , 1993, Journal of the Neurological Sciences.
[4] Marcel Leist,et al. Caspase inhibition reduces apoptosis and increases survival of nigral transplants , 1999, Nature Medicine.
[5] P. Brundin,et al. Treatment with the spin-trap agent α-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons , 1998, Brain Research.
[6] Lars Björklund,et al. Tirilazad Mesylate Increases Dopaminergic Neuronal Survival in thein OculoGrafting Model , 1997, Experimental Neurology.
[7] E. Mufson,et al. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies , 1996, The Journal of comparative neurology.
[8] K. Rich,et al. Flunarizine protects neurons from death after axotomy or NGF deprivation. , 1990, Science.
[9] G. Krause,et al. Effect of flunarizine on global brain ischemia in the dog: A quantitative morphologic assessment , 1987, Experimental Neurology.
[10] Jenny Karlsson,et al. Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches , 2000, Cell transplantation.
[11] M. E. Eichler,et al. The Ability of Diphenylpiperazines to Prevent Neuronal Death in Dorsal Root Ganglion Neurons In Vitro After Nerve Growth Factor Deprivation and In Vivo After Axotomy , 1994, Journal of neurochemistry.
[12] P. Brundin,et al. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Fawcett,et al. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. , 1996, Neuroreport.
[14] P. Brundin,et al. Excitotoxicity Plays a Role in the Death of Tyrosine Hydroxylase- Immunopositive Nigral Neurons Cultured in Serum-Free Medium , 1999, Experimental Neurology.
[15] A. Carvalho,et al. Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas. , 1991, European journal of pharmacology.
[16] P. Brundin,et al. Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones 1 Published on the World Wide Web on 4 February 1999. 1 , 1999, Brain Research.
[17] J. Leysen,et al. Ca++ and Na+ channels involved in neuronal cell death. Protection by flunarizine. , 1991, Life sciences.
[18] J. Fawcett,et al. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—II. Effects on nigral transplantsin vivo , 1993, Neuroscience.
[19] P. Kostyuk,et al. Dihydropyridine‐sensitive low‐threshold calcium channels in isolated rat hypothalamic neurones. , 1989, The Journal of physiology.
[20] E. Clarkson,et al. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats , 1998, Brain Research.
[21] T. Wieloch,et al. Flunarizine, a Calcium Entry Blocker, Ameliorates Ischemic Brain Damage in the Rat , 1986, Anesthesiology.
[22] A. Björklund,et al. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. , 1996, Neuroscience.
[23] W. Hass,et al. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil , 1988, British journal of pharmacology.
[24] R. Hauser,et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[25] G. Owens,et al. Programmed Cell Death in Developing Grafts of Fetal Substantia Nigra , 1994, Experimental Neurology.
[26] H. Takagi,et al. U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. , 1994, European journal of pharmacology.
[27] P. Nicotera,et al. Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis , 1997, The Journal of experimental medicine.